prazosin has been researched along with Cirrhoses, Experimental Liver in 2 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y | 1 |
| Liu, H | 1 |
| Gaskari, SA | 1 |
| Tyberg, JV | 1 |
| Lee, SS | 1 |
| Altmann, O | 1 |
2 other studies available for prazosin and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
Altered mesenteric venous capacitance and volume pooling in cirrhotic rats are mediated by nitric oxide.
Topics: Animals; Blood Volume; Hemorrhage; Liver Cirrhosis, Experimental; Mesenteric Veins; NG-Nitroarginine | 2008 |
[Pharmacological lowering of portal pressure in normal rats and in experimental liver cirrhosis].
Topics: Acute Disease; Animals; Blood Pressure; Canrenoic Acid; Heart Rate; Hypertension, Portal; Liver Cirr | 1991 |